| Evaluating preferences for online psychological interventions to decrease cannabis use in young adults with psychosis: An observational study O Tatar, A Abdel-Baki, A Dyachenko, H Bakouni, A Bahremand, PG Tibbo, ... Psychiatry research 326, 115276, 2023 | 2 | 2023 |
| Reducing cannabis use in young adults with psychosis using iCanChange, a mobile health app: protocol for a pilot randomized controlled trial (ReCAP-iCC) O Tatar, A Abdel-Baki, A Wittevrongel, T Lecomte, J Copeland, ... JMIR research protocols 11 (11), e40817, 2022 | 7 | 2022 |
| Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder L Mills, A Dunlop, M Montebello, J Copeland, R Bruno, M Jefferies, ... Substance Abuse Treatment, Prevention, and Policy 17 (1), 67, 2022 | 4 | 2022 |
| Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial M Montebello, M Jefferies, L Mills, R Bruno, J Copeland, I McGregor, ... Drug and Alcohol Dependence 234, 109388, 2022 | 1 | 2022 |
| Reducing Cannabis Use in Young Adults with Psychosis Using iCanChange, a Mobile Health Application: Protocol for a Pilot Randomized Controlled Trial (ReCAP-iCC) O Tatar, A Abdel-Baki, A Wittevrongel, T Lecomte, J Copeland, ... JMIR Preprints 6, 1-32, 2022 | | 2022 |
| KEEP IT REAL: A WEB-BASED RANDOMISED CONTROLLED TRIAL FOR REDUCING CANNABIS USE AND PSYCHOTIC EXPERIENCES IN YOUNG PEOPLE L Hides, J Leung, G Newland, AL Baker, M Norberg, J Copeland, ... Drug and Alcohol Review 40, S80-S80, 2021 | | 2021 |
| Test-retest reliability and cross-cultural applicability of DSM-5 adopted diagnostic criteria for ketamine use disorders ND Fitzgerald, CW Striley, JJ Palamar, J Copeland, S Kurtz, LB Cottler Drug and alcohol dependence 228, 109056, 2021 | 2 | 2021 |
| Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial N Lintzeris, L Mills, A Dunlop, J Copeland, I Mcgregor, R Bruno, A Kirby, ... Drug and Alcohol Dependence 215, 108220, 2020 | 24 | 2020 |
| Cannabis use among US adults with anxiety from 2008 to 2017: The role of state-level cannabis legalization AH Weinberger, J Zhu, J Levin, JL Barrington-Trimis, J Copeland, K Wyka, ... Drug and alcohol dependence 214, 108163, 2020 | 28 | 2020 |
| Cannabis use is associated with increased risk of cigarette smoking initiation, persistence, and relapse among adults in the United States AH Weinberger, CD Delnevo, K Wyka, M Gbedemah, J Lee, J Copeland, ... Nicotine and Tobacco Research 22 (8), 1404-1408, 2020 | 73 | 2020 |
| A web-based program for cannabis use and psychotic experiences in young people (keep it real): protocol for a randomized controlled trial L Hides, A Baker, M Norberg, J Copeland, C Quinn, Z Walter, J Leung, ... JMIR research protocols 9 (7), e15803, 2020 | 21 | 2020 |
| Validation of the Australian Treatment Outcomes Profile for use in clients with cannabis dependence L Mills, N Lintzeris, R Bruno, M Montebello, A Dunlop, RM Deacon, ... Drug and Alcohol Review 39 (4), 356-364, 2020 | 9 | 2020 |
| Cannabis use among youth in the United States, 2004–2016: Faster rate of increase among youth with depression AH Weinberger, J Zhu, J Lee, E Anastasiou, J Copeland, RD Goodwin Drug and alcohol dependence 209, 107894, 2020 | 39 | 2020 |
| Clinical Significance and Outcomes in Trial of Nabiximols for Treatment of Cannabis Dependence—Reply N Lintzeris, J Copeland, R Bruno JAMA Internal Medicine 180 (1), 163-164, 2020 | 1 | 2020 |
| Health care engagement behaviors of men who use performance-and image-enhancing drugs in Australia B Jacka, B Larance, J Copeland, L Burns, M Farrell, E Jackson, ... Substance Abuse 41 (1), 139-145, 2020 | 21 | 2020 |
| A smartphone app intervention for adult cannabis users wanting to quit or reduce their use: a pilot evaluation L Albertella, L Gibson, S Rooke, MM Norberg, J Copeland Journal of cannabis research 1, 1-10, 2019 | 16 | 2019 |
| EFFICACY OF NABIXIMOLS IN REDUCING FREQUENCY OF CANNABIS USE THREE MONTHS AFTER TREATMENT CESSATION: RESULTS FROM A RANDOMISED CONTROLLED TRIAL N Lintzeris, L Mills, AJ Dunlop, J Copeland, I McGregor, R Bruno, ... DRUG AND ALCOHOL REVIEW 38, S66-S67, 2019 | | 2019 |
| Nabiximols for the treatment of cannabis dependence: a randomized clinical trial N Lintzeris, A Bhardwaj, L Mills, A Dunlop, J Copeland, I McGregor, ... JAMA internal medicine 179 (9), 1242-1253, 2019 | 91 | 2019 |
| Research protocol for a randomized controlled trial of Keep it Real, a web-based program for cannabis use and psychotic experiences in young people L Hides, A Baker, M Norberg, J Copeland, C Quinn, Z Walter, J Leung, ... JMIR Research Protocols 9 (7), e15803, 2019 | | 2019 |
| Pharmacological treatment of cannabis use disorder. J Copeland American Psychological Association, 2019 | | 2019 |